Extension to Safety and Efficacy of Probuphine in the Treatment of Opioid Dependence
Public ClinicalTrials.gov record NCT00630201. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label, Multi-Center Extension Study Of Probuphine in Patients With Opioid Dependence
Study identification
- NCT ID
- NCT00630201
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Titan Pharmaceuticals
- Industry
- Enrollment
- 62 participants
Conditions and interventions
Conditions
Interventions
- Probuphine (buprenorphine implant) Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2007
- Primary completion
- Jan 31, 2009
- Completion
- Jan 31, 2009
- Last update posted
- Dec 30, 2018
2007 – 2009
United States locations
- U.S. sites
- 15
- U.S. states
- 11
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| David Geffen School of Medicine at UCLA | Los Angeles | California | — | — |
| Synergy Clinical Research Center | National City | California | 91950 | — |
| Amit Vijapura, MD | Jacksonville | Florida | 32256 | — |
| Fidelity Clinical Research, Inc. | Lauderhill | Florida | — | — |
| Scientific Clinical Research, Inc. | North Miami | Florida | 33161 | — |
| Behavioral Biology Research Unit, Johns Hopkins Bayview Campus | Baltimore | Maryland | — | — |
| Dual Diagnosis Unit, SSTAR: Stanley Street Treatment and Resources, Inc. | Fall River | Massachusetts | — | — |
| Wayne State Univ. School of Medicine, Dept of Psychiatry & Behavioral Neuroscience | Detroit | Michigan | — | — |
| Psych Care Consultants Research | St Louis | Missouri | 63128 | — |
| New York VA Medical Center, NYU School of Medicine | New York | New York | — | — |
| Duke Addictions Program | Durham | North Carolina | 27705 | — |
| Pahl Pharmaceutical Research, LLC | Oklahoma City | Oklahoma | 73118 | — |
| University of Pennsylvania, Treatment Research Center | Philadelphia | Pennsylvania | 19104 | — |
| Providence Behavioral Health Services | Everett | Washington | 98201-1067 | — |
| Puget Sound Health CareSystem | Seattle | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00630201, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 30, 2018 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00630201 live on ClinicalTrials.gov.